Telix Pharmaceuticals Ltd

TLX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002007191

SEC filings (opens in a new tab)

No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.

Other share classesTLPPF

Q3 2025 vs. Q2 2025

How the institutions holding Telix Pharmaceuticals Ltd changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of TLX: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Q3 2025	Change
Holders	21	27	+6
Shares	452.5K	823.2K	+370.7K (+81.9%)
Value	$7.29M	$7.88M	+$592.0K (+8.1%)

New holders (13)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TLX in Q3 2025
Institution	Shares	Value	% of portfolio
Millennium Management LLC	196,741	$1.88M	0.00%
Portland Investment Counsel Inc.	128,000	$1.22M	0.34%
Lazard Asset Management LLC	114,624	$1.10M	0.00%
Marshall Wace, LLP	48,573	$464.8K	0.00%
JPMorgan Chase & Co	25,355	$242.6K	0.00%
HRT Financial LP	11,641	$111.0K	0.00%
GWM Advisors LLC	2,400	$23.0K	0.00%
Bank of America Corp	2,150	$20.6K	0.00%
State of Wyoming	1,293	$12.4K	0.00%
Ronald Blue Trust, Inc.	1,206	$11.5K	0.00%
Larson Financial Group LLC	53	$507	0.00%
Transamerica Financial Advisors, Inc.	25	$239	0.00%
Farther Finance Advisors, LLC	9	$86	0.00%

Sold out (7)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of TLX in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Pier Capital, LLC	188,992	$3.04M
Russell Investments Group, Ltd.	60,301	$975.1K
Citadel Advisors LLC	41,328	$668.3K
Blair William & Co	13,500	$216.9K
Raymond James Financial Inc	1,200	$19.3K
Royal Bank of Canada	141	$2.00K
JFS Wealth Advisors, LLC	27	$434